Denizot Y, Trimoreau F, Dupuis F, Verger C, Praloran V
Laboratoire d'Hématologie Expérimentale, Faculté de Médecine, Limoges, France.
Biochim Biophys Acta. 1995 Feb 16;1265(1):55-60. doi: 10.1016/0167-4889(94)00193-i.
Platelet-activating factor (PAF) is a phospholipid compound with major immunoregulatory activities. The present study shows that human bone marrow contains 576 +/- 39 pg PAF/ml (n = 35). Bone marrow-derived PAF exhibits the same biophysical and biological properties that synthetic PAF. PAF concentrations in bone marrow are correlated with the granulocyte (r = 0.4, P = 0.02) but not with the lymphocyte (r = 0.24, P = 0.17) and the monocyte (r = 0.12, P = 0.48) counts. In bone marrow PAF is inactivated by a plasma PAF acetylhydrolase activity (48.0 +/- 2.3 nmol/min per ml, n = 34). Experiments with [3H]PAF indicate that human bone marrow cells actively metabolize this potent molecule by the deacetylation-transacylation pathway. Results of this investigation indicate the permanent presence of significant amounts of PAF in bone marrow suggesting its putative involvement in the processes of bone marrow cell proliferation and maturation.
血小板活化因子(PAF)是一种具有主要免疫调节活性的磷脂化合物。本研究表明,人骨髓中PAF含量为576±39 pg/ml(n = 35)。骨髓来源的PAF具有与合成PAF相同的生物物理和生物学特性。骨髓中PAF的浓度与粒细胞计数相关(r = 0.4,P = 0.02),但与淋巴细胞计数(r = 0.24,P = 0.17)和单核细胞计数(r = 0.12,P = 0.48)无关。在骨髓中,PAF被血浆PAF乙酰水解酶活性灭活(48.0±2.3 nmol/(min·ml),n = 34)。用[3H]PAF进行的实验表明,人骨髓细胞通过脱乙酰化-转酰基化途径积极代谢这种强效分子。本研究结果表明,骨髓中持续存在大量PAF,提示其可能参与骨髓细胞增殖和成熟过程。